Weeks 4-8: Waist circumference begins to decrease as visceral fat reduces
SELECT Trials Groundbreaking Results In 2023, in a landmark finding, the SELECT trial showed that adults with overweight or obesity but without diabetes, who had previously experienced a heart attack, stroke and/or had peripheral artery disease, taking semaglutide had a 20% reduction in major adverse cardiac events such as heart attacks and strokes compared to those on placebo over the course of 3 years
Clinical Update 10/30/2025 Heartburn Meds & Carnitine Loss A common heartburn medication may deplete carnitine, according to a recent study
Patients with a history of bipolar disorder, severe anxiety, or psychosis might experience worsening of symptoms
In the last 2 h of the 24-h permeability assays, the acceptor compartments were supplemented with Hoechst 33342 dye (2 g/ml) to label the cell nuclei of organoids
Book your session now and help your body eliminate toxins for renewed energy and wellness!